NEU neuren pharmaceuticals limited

I think allocating an additional $100m sends mixed signals...

  1. 2,499 Posts.
    lightbulb Created with Sketch. 681
    I think allocating an additional $100m sends mixed signals because the company has been telling the market they are funded to run the Phase 3's themselves. I think that additional cash would be the buffer for the PH trial and unexpected costs that may arise. I was thinking $25m~ at most but I also understand if the company thinks no additional SBB after the $50m is exhausted. We know the selling pressure isn't gone (that's just the market) but at the very least we seem to have turned a corner momentum wise, and that's something. Let's hope it holds.

    I do hope the theory about BT is correct. That would go along way to make sure our lows aren't repeated and we grind back to where we should be price wise.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.